Insomnia
📧 Sign up to get email alerts when something new happens for Insomnia.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2019-08-27FDA Approved: TEMAZEPAM — Supplemental Application (Ascend Laboratories, LLC)
FDA approved a supplemental application for Temazepam by Ascend Laboratories, LLC. This action authorizes a supplemental approval to an exis…
-
CLINICAL_TRIALS trial_result · 2019-08-19Clinical Trial Update: Making Better Lives: Patient-Focused Care for Low Back Pain (LBP) [NA]
A completed clinical trial sponsored by the VA exploring patient-focused care for chronic low back pain and related conditions, with results…
-
FDA approval · 2019-08-18FDA Approved: LUNESTA — Supplemental Application (Waylis Therapeutics LLC)
The FDA approved a supplemental application for LUNESTA (eszopiclone) submitted by Waylis Therapeutics LLC.
-
FDA approval · 2019-08-18FDA Approved: AMBIEN — Supplemental Application (Cosette Pharmaceuticals, Inc.)
The FDA approved a supplemental application from Cosette Pharmaceuticals, Inc. for Ambien (zolpidem tartrate) under NDA 019908. The action r…
-
FDA approval · 2019-08-18FDA Approved: ZOLPIDEM TARTRATE — Supplemental Application (Sanofi-Aventis U.S. LLC)
FDA approved a supplemental application for zolpidem tartrate submitted by Sanofi-Aventis U.S. LLC.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2019-08-18FDA Approved: EDLUAR — Supplemental Application (Viatris Specialty LLC)
The FDA approved a supplemental application for EDLUAR (zolpidem tartrate) from Viatris Specialty LLC.
-
CLINICAL_TRIALS trial_result · 2019-08-05Clinical Trial Update: To Compare the Effectiveness of Suvorexant vs Placebo on Sleep Pressure in Hypertensives With Insomnia [Phase 4]
A Phase 4 trial comparing suvorexant to placebo for sleep pressure in hypertensive patients with insomnia has completed with results posted …
-
CLINICAL_TRIALS trial_result · 2019-07-30Clinical Trial Update: Blue Blockers at Night and Insomnia Symptoms [NA]
Clinical trial update for blue blockers at night addressing insomnia and sleep symptoms; study completed with results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-07-22Clinical Trial Update: The Exploratory Study to Investigate the Effect of Ramelteon for Insomnia Patients With Major Depressive Disorder by Using Actigraphy [Phase 4]
Phase 4 exploratory trial assessing ramelteon for insomnia in patients with major depressive disorder; results posted after completion.
-
FDA approval · 2019-07-22FDA Approved: RAMELTEON — Original Application (Zydus Pharmaceuticals USA Inc.)
FDA approves the original ANDA for ramelteon from Zydus Pharmaceuticals USA Inc., enabling a generic version of this insomnia medication. Ra…
-
CLINICAL_TRIALS trial_result · 2019-06-21Clinical Trial Update: Study of Trazodone & Cognitive Behavioral Therapy to Treat Insomnia [NA]
Clinical trial investigating trazodone plus cognitive behavioral therapy for insomnia has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2019-06-17Clinical Trial Update: Effectiveness of BBT-I and Zopiclone for Chronic Insomnia [Phase 2]
Phase 2 trial update evaluating the effectiveness of BBT-I and zopiclone for chronic insomnia; study completed with posted results.
-
CLINICAL_TRIALS trial_result · 2019-06-17Clinical Trial Update: Challenging the Inflammatory Response System in Insomnia Disorder
Clinical trial investigating inflammatory response in insomnia disorder has completed; results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-06-03Clinical Trial Update: Novel Treatment of Comorbid Insomnia and Sleep Apnea in Older Veterans [NA]
Completed clinical trial investigating a novel treatment for comorbid insomnia and sleep apnea in older veterans; results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-05-31Clinical Trial Update: Insomnia Treatment for Women Veterans [NA]
Clinical trial update for insomnia treatment in women veterans; study completed and results posted in 2019.
-
FDA approval · 2019-03-27FDA Approved: DOXEPIN HYDROCHLORIDE — Original Application (Aurobindo Pharma Limited)
FDA approved the original application for doxepin hydrochloride from Aurobindo Pharma Limited, granting generic approval for this product.
-
CLINICAL_TRIALS trial_result · 2019-03-04Clinical Trial Update: Sustainable Methods, Algorithms, and Research Tools for Delivering Optimal Care Study [NA]
A completed clinical trial conducted by Stanford University evaluating sustainable methods, algorithms, and tools to deliver optimal care fo…
-
CLINICAL_TRIALS trial_result · 2019-02-27Clinical Trial Update: A Six Week, Randomized, Double-Blind Placebo-Controlled, Suvorexant Augmentation Study of Antidepressant Treatment of Major Depressive Disorder With Residual Insomnia [Phase 4]
Six-week randomized, double-blind, placebo-controlled trial evaluating suvorexant augmentation to antidepressant treatment in major depressi…
-
FDA approval · 2019-02-26FDA Approved: HYDROXYZINE HYDROCHLORIDE — Original Application (APOZEAL PHARMACEUTICALS INC)
The FDA approved APOZEAL Pharmaceuticals' original application for hydroxyzine hydrochloride, establishing a generic version of this antihis…
-
CLINICAL_TRIALS trial_result · 2019-02-15Clinical Trial Update: Toileting at Night in Older Adults: Light to Maximize Balance, Minimize Insomnia [NA]
A completed VA-sponsored trial tested light exposure during nighttime toileting to improve balance and reduce insomnia in older adults at ri…
-
FDA approval · 2019-02-06FDA Approved: AMBIEN — Supplemental Application (Cosette Pharmaceuticals, Inc.)
The FDA approved a supplemental application for AMBIEN (zolpidem tartrate) submitted by Cosette Pharmaceuticals, Inc.
-
FDA approval · 2019-02-06FDA Approved: ZOLPIDEM TARTRATE — Supplemental Application (Sanofi-Aventis U.S. LLC)
FDA approved a supplemental application for zolpidem tartrate (Ambien) submitted by Sanofi-Aventis U.S. LLC.
-
FDA approval · 2019-02-06FDA Approved: HALCION — Supplemental Application (Pharmacia & Upjohn Company LLC)
The FDA approved a supplemental application for HALCION (triazolam) filed by Pharmacia & Upjohn Company LLC.
-
FDA approval · 2019-02-06FDA Approved: RESTORIL — Supplemental Application (SpecGx LLC)
The FDA approved a supplemental application for Restoril (temazepam) submitted by SpecGx LLC.
-
FDA approval · 2019-02-06FDA Approved: FLURAZEPAM HYDROCHLORIDE — Supplemental Application (Chartwell RX, LLC)
FDA approved a supplemental application for Flurazepam Hydrochloride filed by Chartwell RX, LLC.